HGVS Recommendations for the Description of Sequence Variants: 2016 Update

The consistent and unambiguous description of sequence variants is essential to report and exchange information on the analysis of a genome. In particular, DNA diagnostics critically depends on accurate and standardized description and sharing of the variants detected. The sequence variant nomenclature system proposed in 2000 by the Human Genome Variation Society has been widely adopted and has developed into an internationally accepted standard. The recommendations are currently commissioned through a Sequence Variant Description Working Group (SVD‐WG) operating under the auspices of three international organizations: the Human Genome Variation Society (HGVS), the Human Variome Project (HVP), and the Human Genome Organization (HUGO). Requests for modifications and extensions go through the SVD‐WG following a standard procedure including a community consultation step. Version numbers are assigned to the nomenclature system to allow users to specify the version used in their variant descriptions. Here, we present the current recommendations, HGVS version 15.11, and briefly summarize the changes that were made since the 2000 publication. Most focus has been on removing inconsistencies and tightening definitions allowing automatic data processing. An extensive version of the recommendations is available online, at http://www.HGVS.org/varnomen.

[1]  Vincent A. Fusaro,et al.  A Python package for parsing, validating, mapping and formatting sequence variants using HGVS nomenclature , 2014, Bioinform..

[2]  Celeste M Condit,et al.  The changing meanings of “mutation:” A contextualized study of public discourse , 2002, Human mutation.

[3]  R. E. Tully,et al.  Locus Reference Genomic sequences: an improved basis for describing human DNA variants , 2010, Genome Medicine.

[4]  S. Antonarakis.  Recommendations for a nomenclature system for human gene mutations , 1998 .

[5]  Nicola Wolstenholme,et al.  What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases , 2016, Human mutation.

[6]  M Schwab,et al.  Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting , 2016, Clinical pharmacology and therapeutics.

[7]  Manfred Stuhrmann,et al.  Mutation nomenclature in practice: Findings and recommendations from the cystic fibrosis external quality assessment scheme , 2011, Human mutation.

[8]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[9]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[10]  M. Gulley,et al.  Clinical laboratory reports in molecular pathology. , 2007, Archives of pathology & laboratory medicine.

[11]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[12]  Update on nomenclature for human gene mutations , 2022 .

[13]  André Blavier,et al.  A formalized description of the standard human variant nomenclature in Extended Backus-Naur Form , 2011, BMC Bioinformatics.

[14]  Johan T den Dunnen,et al.  Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker , 2008, Human mutation.

[15]  R. Cotton.  Communicating “mutation:” Modern meanings and connotations , 2002, Human mutation.

[16]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[17]  Jacqueline A. L. MacArthur,et al.  Locus Reference Genomic: reference sequences for the reporting of clinically relevant sequence variants , 2013, Nucleic Acids Res..

[18]  Portland Press Ltd.  IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983 , 1984 .